@article {Ramirojrheum.181070, author = {Sofia Ramiro and Matthew J. Page and Samuel L. Whittle and Hsiaomin Huang and Arianne P. Verhagen and Dorcas Beaton and Pamela Richards and Marieke Scholte-Voshaar and Beverley Shea and Danielle van der Windt and Christian Kopkow and Mario Lenza and Nitin Jain and Bethan Richards and Catherine L. Hill and Tiffany K. Gill and Bart Koes and Nadine Foster and Philip G. Conaghan and Toby O. Smith and Peter Malliaras and Yngve Roe and Joel J Gagnier and Rachelle Buchbinder}, title = {The Omeract Core Domain Set for Clinical Trials of Shoulder Disorders}, elocation-id = {jrheum.181070}, year = {2019}, doi = {10.3899/jrheum.181070}, publisher = {The Journal of Rheumatology}, abstract = {Objective To reach consensus on the core domains to be included in a core domain set for clinical trials of shoulder disorders using the OMERACT Filter 2.1 Core Domain Set process. Methods At OMERACT 2018, the Outcome Measures in Rheumatology (OMERACT) Shoulder Working Group conducted a workshop that presented the OMERACT 2016 preliminary core domain set and its rationale based upon a systematic review of domains measured in shoulder trials and an international Delphi involving patients, clinicians and researchers, as well as a new systematic review of qualitative studies on the experiences of people with shoulder disorders. After discussions in break-out groups, the OMERACT core domain set for clinical trials of shoulder disorders was presented for endorsement by OMERACT 2018 participants. Results The qualitative review (N=8) identified all domains included in the preliminary core set. An additional domain, cognitive dysfunction was also identified but confidence that this represents a core domain was very low. The core domain set that was endorsed by the OMERACT participants, with 71\% agreement, includes four {\textquoteleft}mandatory{\textquoteright} trial domains: pain, function, patient global - shoulder and adverse events including death; and four {\textquoteleft}important but optional{\textquoteright} domains: participation (recreation/work), sleep, emotional wellbeing and condition-specific pathophysiological manifestations. Cognitive dysfunction was voted out of the core domain set. Conclusion OMERACT 2018 delegates endorsed a core domain set for clinical trials of shoulder disorders. The next step includes identification of a core outcome measurement set that passes the OMERACT 2.1 Filter for measuring each domain.}, issn = {0315-162X}, URL = {https://www.jrheum.org/content/early/2019/01/23/jrheum.181070}, eprint = {https://www.jrheum.org/content/early/2019/01/23/jrheum.181070.full.pdf}, journal = {The Journal of Rheumatology} }